- This event has passed.
Pipeline strategy: Measuring the return from pharmaceutical innovation
April 22, 2025 @ 11:00 am – 12:00 pm EDT
Free
1 CPE credit
Return on investment in biopharmaceutical R&D has increased for the second consecutive year, to 5.9%, driven by a surge in high-value products entering the late-stage pipeline. However, this progress appears fragile as rising R&D costs continue to pose a challenge to sustainable R&D. We’ll discuss:
A bold approach that may be needed to continue uptick in returns and meet growing demand
Current state of R&D returns for 20 leading biopharma companies
Changing pipeline composition and opportunities that exist outside of oncology and infectious diseases
